Clinical trial · Interventional
Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen
Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen
NCT07215936CI-TRIAL-00096535active not recruitingPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Dose\_dense Capecitabine Schedule in colorectal cancers
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Arm A:Dose_dense Capecitabine in Colorectal cancer | Drug | — | UNRESOLVED |
| Arm B : standard dose Capecitabine | Drug | Capecitabine | ALIAS |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Arm A :will receive capecitabine dose dense 1750 mg /m2 7days on treatment and 7 days off
- interventionNames
- Drug: Arm A:Dose_dense Capecitabine in Colorectal cancer
- type
- ACTIVE_COMPARATOR
- label
- Arm B will receive capecitabine standard dose 1000mg/m2 2weeks on and 1 week off
- interventionNames
- Drug: Arm B : standard dose Capecitabine
Primary outcomes (1)
- measure
- 1_Quality of life assessed through EORTC_QLQ_CR29 questionaire
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients who diagnosed colorectal cancer Performance status ranging from 0 to 2 Both sexs Exclusion Criteria: * pateints with other malignancy Pateints who have other comorbid diseas
References
Publications (0)
Data not yet available
No reference posted for this study.